The effect and safety of the drug Acyclovir in patients of Pityriasis rosea (a widespread red and scaly lesion following infection or drug intake)
Phase 4
- Conditions
- Health Condition 1: null- Patients suffering from Pityriasis rosea
- Registration Number
- CTRI/2013/12/004240
- Lead Sponsor
- Institutional Medical College Kolkata
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 24
Inclusion Criteria
a.All patients presenting with pityriasis rosea.
b.Patients giving informed written consent
Exclusion Criteria
a.Patients not willing to participate in the study
b.Pregnant or breast feeding women
c.Any history of sensitivity to acyclovir or erythromycin or cetirizine
d.Renal or hepatic impairment
e.Suspicion of having fungal infection, psoriasis, or eczema.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assessment of symptoms (Symptom score) on a 0-10 scaleTimepoint: Baseline, 1 week, 2 weeks, 3 weeks, 4 weeks following randomoization
- Secondary Outcome Measures
Name Time Method 1. Spontaneously reported adverse events <br/ ><br>2. Adverse events elicited by the clinicians <br/ ><br>Timepoint: 1 week, 2 weeks, 3 weeks, 4 weeks following randomoization